MAPT and Alzheimer disease: Using this model, the researchers demonstrated that human Aβ derived from a transgenic animal entered the wild-type mouse brain and initiated AD-like pathology, including tau hyperphosphorylation, neurodegeneration, neuroinflammation, impaired hippocampal long-term potentiation, and amyloid plaque formation (Bu et al., 2018).